Figure 6 | Scientific Reports

Figure 6

From: EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway

Figure 6

CXCR4 expression in lung adenocarcinoma patients according to EGFR-L858R mutation status.

The CXCR4 surface protein expression in lung adenocarcinoma cells from EGFR-L858R and EGFR-WT tumors was determined by flow cytometry. Box shows median and interquartile range ± 95% confidence interval. Patient samples were tested in triplicate (*P = 0.025, Mann-Whitney U Test).

Back to article page